Education
About Us
Working with TipRanks
Follow Us
Premier Anti-Aging Co., Ltd. (JP:4934)
:4934
4934 Stock Chart & Stats
¥702.00
-¥12.00(-1.43%)
At close: 4:00 PM EST
¥702.00
-¥12.00(-1.43%)
Day’s Range― - ―
52-Week Range¥642.00 - ¥979.00
Previous CloseN/A
Volume17.40K
Average Volume (3M)11.01K
Market Cap
¥6.49B
Enterprise Value¥2.74B
Total Cash (Recent Filing)¥4.66B
Total Debt (Recent Filing)¥1.11B
Price to Earnings (P/E)3.8
Beta1.02
Next Earnings
Mar 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)46.82
Shares Outstanding8,720,534
10 Day Avg. Volume8,960
30 Day Avg. Volume11,006
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.14
Price to Sales (P/S)0.47
P/FCF Ratio5.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)49.3
Revenue Forecast (FY)¥15.00B
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 76.65% gross margin indicates durable product-level pricing power and low direct costs. High gross margins provide a structural cushion against sales volatility, support investment in marketing/R&D, and allow the company to maintain profitability even if operating expenses rise.
Conservative Balance SheetLow leverage (D/E 0.17) and a healthy equity ratio give the company financial flexibility. This conservative capital structure reduces insolvency risk, supports funding for strategic initiatives or downturns, and preserves optionality for M&A or reinvestment without stressing cash flows.
Improved Free Cash Flow ConversionA marked improvement in free cash flow and FCF/net income ~0.98 demonstrates strong conversion of accounting profits to cash. Durable cash generation enhances the company’s ability to fund operations, pay down liabilities, and invest in long-term growth without relying on external financing.
Bears Say
Declining RevenueSustained revenue decline (reported as -19.4% in the fundamentals and described as multi-year decline in income statement notes) erodes scale and reduces leeway to cover fixed costs. Continued top-line contraction undermines long-term margin improvement and constrains reinvestment and growth options.
Low Net Profit MarginA net margin near 2.9% leaves little buffer against cost inflation or revenue shocks and limits retained earnings available for reinvestment. Over time, persistently thin net margins hamper the company’s ability to scale profitably and reduce resilience to competitive or macroeconomic pressures.
Weak Operational Margins / EfficiencyLow EBIT and EBITDA margins point to structural inefficiencies in operating the business. Without sustainable improvements in operating leverage or cost structure, the company may struggle to convert strong gross margins into meaningful operating profit, constraining long-term return on capital.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥642.00 and its highest was ¥979.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥6.49B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Mar 12, 2026 which is in 3 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Dec 12, 2025. The company reported ¥46.82 earnings per share for the quarter, beating the consensus estimate of N/A by ¥46.82.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of ¥46.82 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.286%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―